Basel Medical Group Ltd, a Singapore-based healthcare operator specializing in orthopedics and general practice, reported a 12.6% revenue increase in fiscal 2025 to approximately US$8.9 million, driven largely by the acquisition of Bethesda Medical’s six general practice clinics. However, this expansion resulted in a significant S$11.1 million impairment of goodwill related to Bethesda, dragging profit before tax into a loss of nearly S$12.5 million. Rising employee expenses and operating costs further weighed on margins. The company holds solid current assets relative to liabilities but faces risks from key practitioner dependence, regulatory compliance, and competitive pressures in Singapore’s private healthcare sector.